JOHN HUEBNER: Open Payments
NPI 1023118411 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 16 payments from 8 companies in 2025. Trend: 2023 $1,223 · 2024 $155 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $349 |
| Novartis Pharmaceuticals Corporation | 5 | $97 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| ABIOMED | 1 | $27 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| HEARTFLOW, INC. | 1 | $20 |
Products named: EMBLEM MRI S-ICD, FARAPULSE, LEQVIO, VERQUVO, WATCHMAN Access System, LifeVest, JARDIANCE, ELIQUIS.
Industry payments across CA — which companies pay providers there.
